Skip to main content

Spectrum Pharmaceuticals Inc

SPPIDelisted Aug 1, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0000831547

Spectrum Pharmaceuticals Inc was delisted on Aug 1, 2023; its insiders filed their last Form 4 on Aug 1, 2023; 78 institutions reported holding it in 13F filings for Q2 2023, worth $56.5M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Spectrum Pharmaceuticals Inc changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of SPPI: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders8775−12
Shares58.4M52.6M−5.84M (−10.0%)
Value$45.6M$22.7M−$22.9M (−50.3%)

New holders (14)

Institutions that held Spectrum Pharmaceuticals Inc at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to SPPI in Q3 2022
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP637,572$274.0K0.04%
Jacobs Levy Equity Management, Inc594,108$255.0K0.00%
Caas Capital Management LP285,441$123.0K0.02%
Ikarian Capital, LLC176,980$76.0K0.04%
Charles Schwab Investment Management Inc82,687$36.0K0.00%
Two Sigma Securities, LLC43,710$19.0K0.00%
Zacks Investment Management40,256$17.0K0.00%
Knott David M Jr36,900$16.0K0.01%
United Asset Strategies, Inc.18,000$8.00K0.00%
Moors & Cabot, Inc.12,400$5.00K0.00%
Independent Advisor Alliance10,800$5.00K0.00%
Vontobel Holding Ltd.10,000$4.00K0.00%
China Universal Asset Management Co., Ltd.1,763$1.00K0.00%
IFP Advisors, Inc295––

Sold out (26)

Institutions that held Spectrum Pharmaceuticals Inc at the end of Q2 2022 and filed for Q3 2022 without it.